Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

SCCE vs WELL vs VTR vs LOAN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SCCE
Sachem Capital Corp. 6.00% Note

REIT - Industrial

Real EstateAMEX • US
Market Cap$1.14B
5Y Perf.-3.1%
WELL
Welltower Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$149.25B
5Y Perf.+121.6%
VTR
Ventas, Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$41.15B
5Y Perf.+40.1%
LOAN
Manhattan Bridge Capital, Inc.

REIT - Mortgage

Real EstateNASDAQ • US
Market Cap$48M
5Y Perf.-33.4%

SCCE vs WELL vs VTR vs LOAN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SCCE logoSCCE
WELL logoWELL
VTR logoVTR
LOAN logoLOAN
IndustryREIT - IndustrialREIT - Healthcare FacilitiesREIT - Healthcare FacilitiesREIT - Mortgage
Market Cap$1.14B$149.25B$41.15B$48M
Revenue (TTM)$-13M$11.63B$6.13B$8M
Net Income (TTM)$4M$1.43B$260M$5M
Gross Margin39.1%-4.3%99.9%
Operating Margin4.4%13.4%58.1%
Forward P/E598.3x78.4x118.0x8.6x
Total Debt$0.00$21.38B$13.22B$23M
Cash & Equiv.$11M$5.03B$741M$178K

SCCE vs WELL vs VTR vs LOANLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SCCE
WELL
VTR
LOAN
StockMar 22May 26Return
Sachem Capital Corp… (SCCE)10096.9-3.1%
Welltower Inc. (WELL)100221.6+121.6%
Ventas, Inc. (VTR)100140.1+40.1%
Manhattan Bridge Ca… (LOAN)10066.6-33.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: SCCE vs WELL vs VTR vs LOAN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LOAN leads in 3 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Welltower Inc. is the stronger pick specifically for dividend income and shareholder returns and recent price momentum and sentiment. SCCE and VTR also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
SCCE
Sachem Capital Corp. 6.00% Note
The Real Estate Income Play

SCCE is the clearest fit if your priority is growth exposure.

  • Rev growth 100.0%, EPS growth 104.3%
  • 100.0% FFO/revenue growth vs VTR's 18.5%
Best for: growth exposure
WELL
Welltower Inc.
The Real Estate Income Play

WELL is the #2 pick in this set and the best alternative if long-term compounding is your priority.

  • 223.1% 10Y total return vs VTR's 65.0%
  • 1.3% yield, 2-year raise streak, vs LOAN's 10.8%
  • +42.7% vs LOAN's -8.5%
Best for: long-term compounding
VTR
Ventas, Inc.
The Real Estate Income Play

VTR is the clearest fit if your priority is income & stability.

  • Dividend streak 1 yrs, beta 0.01, yield 2.1%
  • Beta 0.01 vs SCCE's 0.69
Best for: income & stability
LOAN
Manhattan Bridge Capital, Inc.
The Real Estate Income Play

LOAN carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.

  • Lower volatility, beta 0.12, Low D/E 52.1%, current ratio 31.09x
  • Beta 0.12, yield 10.8%, current ratio 31.09x
  • Lower P/E (8.6x vs 118.0x)
  • 70.0% margin vs VTR's 4.2%
Best for: sleep-well-at-night and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthSCCE logoSCCE100.0% FFO/revenue growth vs VTR's 18.5%
ValueLOAN logoLOANLower P/E (8.6x vs 118.0x)
Quality / MarginsLOAN logoLOAN70.0% margin vs VTR's 4.2%
Stability / SafetyVTR logoVTRBeta 0.01 vs SCCE's 0.69
DividendsWELL logoWELL1.3% yield, 2-year raise streak, vs LOAN's 10.8%
Momentum (1Y)WELL logoWELL+42.7% vs LOAN's -8.5%
Efficiency (ROA)LOAN logoLOAN8.1% ROA vs SCCE's 0.8%

SCCE vs WELL vs VTR vs LOAN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SCCESachem Capital Corp. 6.00% Note

Segment breakdown not available.

WELLWelltower Inc.
FY 2025
Senior Housing - Operating
81.1%$8.5B
Triple Net
11.4%$1.2B
Outpatient Medical
7.5%$782M
VTRVentas, Inc.
FY 2025
Senior Living Operations
74.0%$4.3B
Outpatient Medical And Research Portfolio
15.5%$898M
Triple Net Leased Properties
10.4%$602M
LOANManhattan Bridge Capital, Inc.

Segment breakdown not available.

SCCE vs WELL vs VTR vs LOAN — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLOANLAGGINGSCCE

Income & Cash Flow (Last 12 Months)

LOAN leads this category, winning 4 of 6 comparable metrics.

WELL and SCCE operate at a comparable scale, with $11.6B and -$13M in trailing revenue. LOAN is the more profitable business, keeping 70.0% of every revenue dollar as net income compared to VTR's 4.2%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSCCE logoSCCESachem Capital Co…WELL logoWELLWelltower Inc.VTR logoVTRVentas, Inc.LOAN logoLOANManhattan Bridge …
RevenueTrailing 12 months-$13M$11.6B$6.1B$8M
EBITDAEarnings before interest/tax$551,999$2.8B$2.3B$4M
Net IncomeAfter-tax profit$4M$1.4B$260M$5M
Free Cash FlowCash after capex$3M$2.5B$1.4B$5M
Gross MarginGross profit ÷ Revenue+39.1%-4.3%+99.9%
Operating MarginEBIT ÷ Revenue+4.4%+13.4%+58.1%
Net MarginNet income ÷ Revenue+12.3%+4.2%+70.0%
FCF MarginFCF ÷ Revenue+21.9%+22.4%+62.6%
Rev. Growth (YoY)Latest quarter vs prior year-2.6%+40.3%+22.0%+14.6%
EPS Growth (YoY)Latest quarter vs prior year-81.9%+22.5%0.0%-8.3%
LOAN leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

LOAN leads this category, winning 5 of 6 comparable metrics.

At 8.6x trailing earnings, LOAN trades at a 99% valuation discount to SCCE's 598.3x P/E. On an enterprise value basis, LOAN's 8.9x EV/EBITDA is more attractive than WELL's 66.4x.

MetricSCCE logoSCCESachem Capital Co…WELL logoWELLWelltower Inc.VTR logoVTRVentas, Inc.LOAN logoLOANManhattan Bridge …
Market CapShares × price$1.1B$149.2B$41.1B$48M
Enterprise ValueMkt cap + debt − cash$1.1B$165.6B$53.6B$71M
Trailing P/EPrice ÷ TTM EPS598.25x153.25x160.26x8.63x
Forward P/EPrice ÷ next-FY EPS est.78.42x118.01x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple66.40x24.31x8.94x
Price / SalesMarket cap ÷ Revenue13.99x7.05x4.99x
Price / BookPrice ÷ Book value/share6.41x3.35x3.18x1.12x
Price / FCFMarket cap ÷ FCF456.44x52.41x31.25x9.82x
LOAN leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

LOAN leads this category, winning 6 of 9 comparable metrics.

LOAN delivers a 12.2% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $2 for VTR. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to VTR's 1.05x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs SCCE's 5/9, reflecting strong financial health.

MetricSCCE logoSCCESachem Capital Co…WELL logoWELLWelltower Inc.VTR logoVTRVentas, Inc.LOAN logoLOANManhattan Bridge …
ROE (TTM)Return on equity+2.3%+3.5%+2.1%+12.2%
ROA (TTM)Return on assets+0.8%+2.3%+1.0%+8.1%
ROICReturn on invested capital+0.5%+2.5%+8.5%
ROCEReturn on capital employed+0.6%+3.2%+11.3%
Piotroski ScoreFundamental quality 0–95767
Debt / EquityFinancial leverage0.49x1.05x0.52x
Net DebtTotal debt minus cash-$11M$16.3B$12.5B$22M
Cash & Equiv.Liquid assets$11M$5.0B$741M$178,012
Total DebtShort + long-term debt$0$21.4B$13.2B$23M
Interest CoverageEBIT ÷ Interest expense0.26x1.40x3.38x
LOAN leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

WELL leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $10,257 for LOAN. Over the past 12 months, WELL leads with a +42.7% total return vs LOAN's -8.5%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs LOAN's 5.2% — a key indicator of consistent wealth creation.

MetricSCCE logoSCCESachem Capital Co…WELL logoWELLWelltower Inc.VTR logoVTRVentas, Inc.LOAN logoLOANManhattan Bridge …
YTD ReturnYear-to-date+4.7%+14.3%+12.6%-6.3%
1-Year ReturnPast 12 months+34.8%+42.7%+33.9%-8.5%
3-Year ReturnCumulative with dividends+46.8%+189.5%+94.2%+16.4%
5-Year ReturnCumulative with dividends+28.9%+202.3%+74.8%+2.6%
10-Year ReturnCumulative with dividends+28.9%+223.1%+65.0%+102.8%
CAGR (3Y)Annualised 3-year return+13.7%+42.5%+24.8%+5.2%
WELL leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

VTR leads this category, winning 2 of 2 comparable metrics.

VTR is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than SCCE's 0.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs LOAN's 72.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSCCE logoSCCESachem Capital Co…WELL logoWELLWelltower Inc.VTR logoVTRVentas, Inc.LOAN logoLOANManhattan Bridge …
Beta (5Y)Sensitivity to S&P 5000.69x0.13x0.01x0.12x
52-Week HighHighest price in past year$24.59$219.59$88.50$5.85
52-Week LowLowest price in past year$11.14$142.65$61.76$4.13
% of 52W HighCurrent price vs 52-week peak+97.3%+97.0%+97.8%+72.3%
RSI (14)Momentum oscillator 0–10060.160.256.236.6
Avg Volume (50D)Average daily shares traded5K2.6M3.4M28K
VTR leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — WELL and LOAN each lead in 1 of 2 comparable metrics.

Analyst consensus: WELL as "Buy", VTR as "Buy". Consensus price targets imply 6.3% upside for WELL (target: $227) vs 4.9% for VTR (target: $91). For income investors, LOAN offers the higher dividend yield at 10.82% vs SCCE's 0.85%.

MetricSCCE logoSCCESachem Capital Co…WELL logoWELLWelltower Inc.VTR logoVTRVentas, Inc.LOAN logoLOANManhattan Bridge …
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$226.50$90.80
# AnalystsCovering analysts3432
Dividend YieldAnnual dividend ÷ price+0.8%+1.3%+2.1%+10.8%
Dividend StreakConsecutive years of raises0210
Dividend / ShareAnnual DPS$0.20$2.76$1.86$0.46
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%+0.0%
Evenly matched — WELL and LOAN each lead in 1 of 2 comparable metrics.
Key Takeaway

LOAN leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). WELL leads in 1 (Total Returns). 1 tied.

Best OverallManhattan Bridge Capital, I… (LOAN)Leads 3 of 6 categories
Loading custom metrics...

SCCE vs WELL vs VTR vs LOAN: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is SCCE or WELL or VTR or LOAN a better buy right now?

For growth investors, Sachem Capital Corp.

6. 00% Note (SCCE) is the stronger pick with 100. 0% revenue growth year-over-year, versus 18. 5% for Ventas, Inc. (VTR). Manhattan Bridge Capital, Inc. (LOAN) offers the better valuation at 8. 6x trailing P/E, making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SCCE or WELL or VTR or LOAN?

On trailing P/E, Manhattan Bridge Capital, Inc.

(LOAN) is the cheapest at 8. 6x versus Sachem Capital Corp. 6. 00% Note at 598. 3x. On forward P/E, Welltower Inc. is actually cheaper at 78. 4x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — SCCE or WELL or VTR or LOAN?

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +202. 3%, compared to +2. 6% for Manhattan Bridge Capital, Inc. (LOAN). Over 10 years, the gap is even starker: WELL returned +223. 1% versus SCCE's +28. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SCCE or WELL or VTR or LOAN?

By beta (market sensitivity over 5 years), Ventas, Inc.

(VTR) is the lower-risk stock at 0. 01β versus Sachem Capital Corp. 6. 00% Note's 0. 69β — meaning SCCE is approximately 7129% more volatile than VTR relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 105% for Ventas, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — SCCE or WELL or VTR or LOAN?

By revenue growth (latest reported year), Sachem Capital Corp.

6. 00% Note (SCCE) is pulling ahead at 100. 0% versus 18. 5% for Ventas, Inc. (VTR). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SCCE or WELL or VTR or LOAN?

Manhattan Bridge Capital, Inc.

(LOAN) is the more profitable company, earning 57. 7% net margin versus 0. 0% for Sachem Capital Corp. 6. 00% Note — meaning it keeps 57. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LOAN leads at 81. 6% versus 0. 0% for SCCE. At the gross margin level — before operating expenses — LOAN leads at 76. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SCCE or WELL or VTR or LOAN more undervalued right now?

On forward earnings alone, Welltower Inc.

(WELL) trades at 78. 4x forward P/E versus 118. 0x for Ventas, Inc. — 39. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WELL: 6. 3% to $226. 50.

08

Which pays a better dividend — SCCE or WELL or VTR or LOAN?

All stocks in this comparison pay dividends.

Manhattan Bridge Capital, Inc. (LOAN) offers the highest yield at 10. 8%, versus 0. 8% for Sachem Capital Corp. 6. 00% Note (SCCE).

09

Is SCCE or WELL or VTR or LOAN better for a retirement portfolio?

For long-horizon retirement investors, Ventas, Inc.

(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Both have compounded well over 10 years (VTR: +65. 0%, SCCE: +28. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SCCE and WELL and VTR and LOAN?

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

SCCE

Stable Dividend Mega-Cap

  • Sector: Real Estate
  • Market Cap > $100B
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

WELL

High-Growth Compounder

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 20%
  • Net Margin > 7%
Run This Screen
Stocks Like

VTR

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Dividend Yield > 0.8%
Run This Screen
Stocks Like

LOAN

Dividend Mega-Cap Quality

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 41%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SCCE and WELL and VTR and LOAN on the metrics below

Revenue Growth>
%
(SCCE: -256.5% · WELL: 40.3%)
P/E Ratio<
x
(SCCE: 598.3x · WELL: 153.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.